JP2024506228A5 - - Google Patents

Info

Publication number
JP2024506228A5
JP2024506228A5 JP2023517276A JP2023517276A JP2024506228A5 JP 2024506228 A5 JP2024506228 A5 JP 2024506228A5 JP 2023517276 A JP2023517276 A JP 2023517276A JP 2023517276 A JP2023517276 A JP 2023517276A JP 2024506228 A5 JP2024506228 A5 JP 2024506228A5
Authority
JP
Japan
Prior art keywords
acid
pharmaceutical composition
composition according
polysorbate
glycerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023517276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506228A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/000640 external-priority patent/WO2022058795A1/en
Publication of JP2024506228A publication Critical patent/JP2024506228A/ja
Publication of JP2024506228A5 publication Critical patent/JP2024506228A5/ja
Pending legal-status Critical Current

Links

JP2023517276A 2020-09-16 2021-09-15 脂質関連障害の処置のための組成物および方法 Pending JP2024506228A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063079195P 2020-09-16 2020-09-16
PCT/IB2021/000640 WO2022058795A1 (en) 2020-09-16 2021-09-15 Compositions and methods for the treatment of lipid-related disorders

Publications (2)

Publication Number Publication Date
JP2024506228A JP2024506228A (ja) 2024-02-13
JP2024506228A5 true JP2024506228A5 (cg-RX-API-DMAC7.html) 2024-09-25

Family

ID=80776673

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023517276A Pending JP2024506228A (ja) 2020-09-16 2021-09-15 脂質関連障害の処置のための組成物および方法

Country Status (7)

Country Link
US (1) US20230355584A1 (cg-RX-API-DMAC7.html)
EP (1) EP4213835A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024506228A (cg-RX-API-DMAC7.html)
CN (1) CN116685316A (cg-RX-API-DMAC7.html)
AU (1) AU2021344871A1 (cg-RX-API-DMAC7.html)
IL (1) IL301325A (cg-RX-API-DMAC7.html)
WO (1) WO2022058795A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016203468A1 (en) 2015-06-15 2016-12-22 Raziel Therapeutics Ltd. Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013072915A1 (en) * 2011-11-15 2013-05-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Tricyclic compounds, compositions comprising them and uses thereof
WO2016020919A1 (en) * 2014-08-07 2016-02-11 Raziel Therapeutics Ltd. Compositions comprising tricyclic compounds, and uses thereof

Similar Documents

Publication Publication Date Title
JP2021185179A (ja) 固溶体組成物および心血管疾患における使用
US10857118B2 (en) Compositions and methods for treating intestinal hyperpermeability
US11197852B2 (en) Continuous delivery of lenalidomide and other immunomodulatory agents
EP3238707B1 (en) Compositions and methods for treating intestinal hyperpermeability
US20220000824A1 (en) Treatment of pulmonary arterial hypertension using therapeutically effective oral doses of 10-nitro-9(e)-octadec-9-enoic acid
RU2011149976A (ru) Композиции для непрерывного управления ингибиторами допа-декарбоксилазы
JP2014507429A (ja) 心血管疾患の治療のための組成物および方法
RU2017112149A (ru) Комбинация омега-3 жирной кислоты и SGLT-2 ингибитора для лечения болезней печени
CN111214464A (zh) 包含15-hepe的组合物以及其使用方法
JP2020063259A (ja) 15−hepeを含む組成物及びその使用方法
RU2017112308A (ru) Композиции и способы для лечения бессонницы
KR102437682B1 (ko) 특화된 사전 해소 매개체의 염에 관한 조성물 및 방법
CN108884053A (zh) 预防和/或治疗与衰老有关的认知障碍和神经炎症的方法
JPWO2013031729A1 (ja) 糖尿病性心血管合併症の予防・治療剤
JP6542006B2 (ja) 外用医薬組成物
CN112245419A (zh) 包括15-hepe的组合物以及使用其治疗或预防纤维化的方法
RU2014129437A (ru) Офтальмологическая композиция
WO2016020919A1 (en) Compositions comprising tricyclic compounds, and uses thereof
TW201328727A (zh) 具改良穩定性之包含ω-3脂肪酸及HMG-CoA還原酶抑制劑的口服複合調配物
KR20100041891A (ko) 간염세포 및/또는 간경변 세포의 형질전환을 억제하는 간암 예방제
JP2018510206A5 (cg-RX-API-DMAC7.html)
US20240424016A1 (en) Buffering for non-alcoholic steatohepatitis and liver diseases
CN114945374A (zh) 药物组合物和方法
JP2023531918A5 (cg-RX-API-DMAC7.html)
JPWO2018016596A1 (ja) PPARαアゴニストを含有する、肺高血圧症の予防又は治療剤